The case of emergency approval of Covaxin from the World Health Organization (WHO) has now been postponed till next week. WHO experts and an independent group will meet after a week on this issue. The benefits and risks of the vaccine will be assessed in this meeting itself.
A meeting of the WHO’s Strategic Advisory Group of Experts (SAGE) was held on Tuesday, but no result could be reached regarding Covaxin. In this meeting, Bharat Biotech sent the necessary documents for the approval of the vaccine.
After Corona, now there are signs of improvement in the economy. Moody’s has given India’s long term rating stable and positive. Last time it was negative. It is based on foreign currency and local currency. Last time the rating was Baa2, now it has been changed to Baa3. The local currency rating has also been raised to P-3.
In fact, due to Corona, Moody’s reduced India’s sovereign rating in June last year. The country’s economy was feared to have a bad effect due to the first wave of Corona. Because of this Moody’s downgraded the rating from Baa2 to Baa3. Last month, the international firm had said that economic activity in India is picking up. The economy is showing improvement with the easing of Kovid restrictions.
